Neurological
Technical Features
-
Neurological
Boston Scientific's Vercise Genus DBS Earns FDA Approval
Fourth-generation DBS portfolio features full-body MR conditional devices.Sam Brusco, Associate Editor 01.22.21
-
Neurological
Cognito Therapeutics’ Lead Product Receives FDA Breakthrough Device Designation
Next-generation digital therapeutic is designed for the treatment of Alzheimer’s disease.Business Wire 01.14.21
-
Neurological
Medtronic Begins Adaptive Deep Brain Stimulation Trial for Parkinson's
First-of-its-kind study tests automated therapy that responds to brain signals in Parkinson's patients.PR Newswire 01.14.21
-
Neurological | Surgical
FDA OKs ClearMind Biomedical's Axonpen Neuroendoscope
Requires only a narrow channel of 6.5mm through the skull for insertion into the brain.PR Newswire 01.12.21
-
Diagnostics | Neurological
FDA OKs Abbott's First-of-Its-Kind Rapid, Handheld TBI Test
Produces a result within 15 minutes after a plasma sample is inserted.Abbott Laboratories 01.11.21
-
Neurological
BioSerenity Achieves FDA Clearance for Wearable Device System
Neuronaute EEG System and IceCap bring comprehensive remote electroencephalography monitoring services to people living with neurological disorders.PRNewswire 01.07.21
-
Cardiovascular | Neurological | Surgical
FDA OKs Rapid Medical's Steerable Neurovascular Guidewire
Provides efficient access in difficult neuro and peripheral vascular procedures.Business Wire 01.04.21
-
Neurological
'Smart Wrap' Implant May Help Improve Bladder Control
Delivers light to the bladder for optogenetic neuromodulation of underactive bladders.Penn State 11.12.20
-
Neurological | Patient Monitoring
FDA OKs Nightware's Device to Reduce Nightmare-Based Sleep Disturbance
Device provides gentle vibration through touch based on analysis of heart rate and motion during sleep.U.S. Food and Drug Administration 11.09.20
-
Neurological
Salvia BioElectronics' Neurostim System for Chronic Migraine Earns Breakthrough Status
Bioelectronics solution addresses drug-refractory chronic migraine.PR Newswire 11.03.20
-
Diagnostics | Neurological | Patient Monitoring
Medtronic Buys Ai Biomed; Earns FDA Nod for NIM Vital Nerve Monitor
New technologies address most common challenges during head and neck surgery.PR Newswire 10.29.20
-
Neurological
First-Ever Treatment Shown to Reverse Alzheimer’s Earns Breakthrough Status
Revolutionary clinical-stage head device to beat back Alzheimer’s disease at home.Business Wire 10.28.20
-
Neurological
FDA OKs CEFALY DUAL Migraine Treatment for Use Without Prescription
First external Trigeminal nerve stimulator for the treatment of migraine headaches.PR Newswire 10.13.20
-
Neurological
Boston Scientific Launches Spinal Cord Stimulator Systems in Europe
Portfolio features full-body MRI conditional devices that combine therapy options for personalized pain relief.PRNewswire 10.01.20
-
Neurological
Medtronic Gets Patent Affirmation of Sacral Neuromodulation Tech
U.S. Patent and Trademark Office rejects IPR challenge to Medtronic patent.PR Newswire 09.28.20
-
Neurological
Health Canada Approval for Axonics’ Implantable Neurostimulator
The next generation INS approved by Health Canada reduces how frequently a patient needs to recharge their implanted device to once a month for about one hour.Business Wire 09.21.20
-
Neurological
Gentle Probes Could Enable Massive Brain Data Collection
NIH awards $4.15 million grant to maximize use of devices based on flexible nanoelectronic thread.Mike Williams, Rice University 09.16.20
-
Diagnostics | Neurological
Creating Diamond Devices to Detect Parkinson's Early
Innovative diamond devices to monitor the brain's biochemistry for early warning signs of disease.Michigan State University 09.14.20
-
Neurological
Boston Scientific Launches Vercise Genus DBS System In Europe
Features full-body MRI conditional and Bluetooth capabilities across the portfolio.PR Newswire 09.10.20
-
Neurological | Surgical
FDA OKs Minnetronix's MindsEye Neurosurgical Access Platform
MindsEye Port is first minimally invasive, expandable port to treat of stroke, cancer, and other conditions.Business Wire 09.09.20
